Open Fracture: Clinical Trials

12 trials for Open Fracture, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 not yet recruiting, 3 recruiting, 2 unknown. 5 Phase 4, 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 45Recruiting 2, Completed 1, Not yet recruiting 1, Terminated 1
Not applicable1Unknown 1
Phase 31Not yet recruiting 1

Follow Open Fracture: new trials by email Literature Review of Open Fracture trials Research Report on Open Fracture

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SurgWeek-2: Identifying the Global Burden of Post Operative Complications: an International Prospective Cohort Study Protocol
Surgery Complications, Surgery
Not yet recruitingUniversity of Birmingham1000002026-08-312026-08-25
Implementation of Vancomycin Powder Application in the Emergency Department for Open Fractures
Vancomycin (VAN) treatment, Standard Open Fracture Care - Open Fracture
Phase 3Not yet recruitingAtlantic Health System1002026-06-102026-06-22
Volume Reduction for Open Fracture Irrigation
0.9% Sodium Chloride - Open Fracture
Phase 4RecruitingInova Health Care Services2002026-03-022026-04-13
Powdered Intrawound Vancomycin in Open Fractures Trial
Vancomycin 1000 MG - Open Fracture, Trauma
Phase 4Not yet recruitingUniversity of Manitoba3502024-11-012024-09-19
Evaluation of STIMULAN Device and AI Model in Preventing Fracture Infections
STIMULAN - Open Fracture
Not applicableUnknownUniversità Vita-Salute San Raffaele402023-11-012024-04-25
OCT in Open Fracture and Infected Fracture
Open Fracture, Infected Fracture - Trauma Injury, Trauma
RecruitingDartmouth-Hitchcock Medical Center402023-03-272026-10-02
Placement of Antibiotic Powder in Wounds During the Emergency Room
Vancomycin - Open Fracture
Phase 4RecruitingThe University of Texas Health Science Center at San Antonio2002020-10-052026-09-30
Septic Management and Outcome of Open Fracture
management and follow up of all open fractures - Open Fracture, Pseudarthrosis
CompletedHospices Civils de Lyon4002020-05-152022-01-12
Noninferiority Comparison of Prophylactic Open Fracture Antimicrobial Regimens
Ceftriaxone, Ampicillin/sulbactam, Piperacillin/tazobactam - Open Fracture, Post-Op Wound Infection
Phase 4TerminatedMercy Health Ohio172018-07-092020-09-11
Preventing Infections in Orthopaedic Patients
Open Fracture
UnknownOlayemi Osiyemi MD502016-11-012016-10-28
Assessment of Severe Extremity Wound Bioburden at the Time of Definitive Wound Closure or Coverage
Open Fracture
CompletedMajor Extremity Trauma Research Consortium6462011-09-012026-05-05
Efficacy of DBM on Fractures of the Shinbone (Tibia)
Grafton DBM, Reamings - Closed Fracture, Open Fracture
Phase 4CompletedEmory University162006-03-012013-09-24

Narrower conditions

Fractures, Open (12)  ·  Infections (3)  ·  Fractures, Bone (2)  ·  Surgical Wound Infection (2)  ·  Wound Infection (2)  ·  Wounds and Injuries (2)  ·  Accidental Injuries (1)  ·  Fractures, Closed (1)  ·  Pseudarthrosis (1)

Broader conditions

Fractures, Bone (10)  ·  Wounds and Injuries (10)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Postoperative Complications (2)  ·  Fractures, Ununited (1)  ·  Infections (1)

Interventions

Therapeutics (3)  ·  Vancomycin (3)  ·  Cefazolin (1)  ·  Ceftriaxone (1)  ·  Clindamycin (1)  ·  Gentamicins (1)  ·  Open Fracture Reduction (1)  ·  Piperacillin, Tazobactam Drug Combination (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)  ·  sultamicillin (1)

Sponsors

Atlantic Health System (1)  ·  Dartmouth-Hitchcock Medical Center (1)  ·  Emory University (1)  ·  Hospices Civils de Lyon (1)  ·  Inova Health Care Services (1)  ·  Major Extremity Trauma Research Consortium (1)  ·  Mercy Health Ohio (1)  ·  Olayemi Osiyemi MD (1)  ·  The University of Texas Health Science Center at San Antonio (1)  ·  University of Birmingham (1)  ·  University of Manitoba (1)  ·  Università Vita-Salute San Raffaele (1)

Countries

United States (8)  ·  Canada (1)  ·  France (1)  ·  Italy (1)

Top investigators

Abraham Goch, MD (1)  ·  Allison R Lauver, PharmD (1)  ·  Chad W Donley, MD (1)  ·  David J Gemmel, PhD (1)  ·  Gabriel Larose, MD, MSc, FRCSC (1)  ·  Ida L Gitajn (1)  ·  Madison Price, MD (1)  ·  Michael J Bosse, MD (1)  ·  Natalie I Rine, PharmD (1)  ·  Olayemi Osiyemi, MD (1)  ·  Paul T Miller, PharmD (1)  ·  Robert A De Lorenzo, MD (1)  ·  Stuart Drew, DO (1)  ·  Thomas J Moore, MD (1)  ·  Tyson T Schrickel, MD (1)